These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Oxidation of methionine residues to methionine sulfoxides does not decrease potential antiatherogenic properties of apolipoprotein A-I. Panzenböck U; Kritharides L; Raftery M; Rye KA; Stocker R J Biol Chem; 2000 Jun; 275(26):19536-44. PubMed ID: 10751387 [TBL] [Abstract][Full Text] [Related]
6. Detection of specifically oxidized apolipoproteins in oxidized HDL. Wang XS; Stocker R Methods Mol Biol; 2008; 477():49-63. PubMed ID: 19082938 [TBL] [Abstract][Full Text] [Related]
7. Methionine oxidized apolipoprotein A-I at the crossroads of HDL biogenesis and amyloid formation. Witkowski A; Chan GKL; Boatz JC; Li NJ; Inoue AP; Wong JC; van der Wel PCA; Cavigiolio G FASEB J; 2018 Jun; 32(6):3149-3165. PubMed ID: 29401604 [TBL] [Abstract][Full Text] [Related]
8. Formation of methionine sulfoxide-containing specific forms of oxidized high-density lipoproteins. Panzenböck U; Stocker R Biochim Biophys Acta; 2005 Jan; 1703(2):171-81. PubMed ID: 15680225 [TBL] [Abstract][Full Text] [Related]
9. Methionine oxidation induces amyloid fibril formation by full-length apolipoprotein A-I. Wong YQ; Binger KJ; Howlett GJ; Griffin MD Proc Natl Acad Sci U S A; 2010 Feb; 107(5):1977-82. PubMed ID: 20133843 [TBL] [Abstract][Full Text] [Related]
10. Increased methionine sulfoxide content of apoA-I in type 1 diabetes. Brock JW; Jenkins AJ; Lyons TJ; Klein RL; Yim E; Lopes-Virella M; Carter RE; ; Thorpe SR; Baynes JW J Lipid Res; 2008 Apr; 49(4):847-55. PubMed ID: 18202432 [TBL] [Abstract][Full Text] [Related]
11. Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I. Shao B; Oda MN; Bergt C; Fu X; Green PS; Brot N; Oram JF; Heinecke JW J Biol Chem; 2006 Apr; 281(14):9001-4. PubMed ID: 16497665 [TBL] [Abstract][Full Text] [Related]
13. Establishment and evaluation of 2 monoclonal antibodies against oxidized apolipoprotein A-I (apoA-I) and its application to determine blood oxidized apoA-I levels. Ueda M; Hayase Y; Mashiba S Clin Chim Acta; 2007 Mar; 378(1-2):105-11. PubMed ID: 17174291 [TBL] [Abstract][Full Text] [Related]
14. Characterization of methionine oxidation and methionine sulfoxide reduction using methionine-rich cysteine-free proteins. Liang X; Kaya A; Zhang Y; Le DT; Hua D; Gladyshev VN BMC Biochem; 2012 Oct; 13():21. PubMed ID: 23088625 [TBL] [Abstract][Full Text] [Related]
15. High density lipoprotein particle size restriction in apolipoprotein A-I(Milano) transgenic mice. Bielicki JK; Forte TM; McCall MR; Stoltzfus LJ; Chiesa G; Sirtori CR; Franceschini G; Rubin EM J Lipid Res; 1997 Nov; 38(11):2314-21. PubMed ID: 9392429 [TBL] [Abstract][Full Text] [Related]
16. High-density lipoprotein oxidation in type 2 diabetic patients and young patients with premature myocardial infarction. Sartore G; Seraglia R; Burlina S; Bolis A; Marin R; Manzato E; Ragazzi E; Traldi P; Lapolla A Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):418-25. PubMed ID: 25636381 [TBL] [Abstract][Full Text] [Related]
17. Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements. Cho KH; Durbin DM; Jonas A J Lipid Res; 2001 Mar; 42(3):379-89. PubMed ID: 11254750 [TBL] [Abstract][Full Text] [Related]
18. Evidence for the presence of lipid-free monomolecular apolipoprotein A-1 in plasma. Miyazaki O; Ogihara J; Fukamachi I; Kasumi T J Lipid Res; 2014 Feb; 55(2):214-25. PubMed ID: 24304668 [TBL] [Abstract][Full Text] [Related]
19. Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism. Hedrick CC; Hassan K; Hough GP; Yoo JH; Simzar S; Quinto CR; Kim SM; Dooley A; Langi S; Hama SY; Navab M; Witztum JL; Fogelman AM Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1946-52. PubMed ID: 10938016 [TBL] [Abstract][Full Text] [Related]